Rani Therapeutics Holdings Inc - Ordinary Shares Class A
NASDAQ:RANI 3:58:01 PM EDT
Earnings Announcements
Rani Therapeutics Reports Q1 2022 Results
Published: 05/11/2022 20:58 GMT
Rani Therapeutics Holdings Inc - Ordinary Shares Class A (RANI) - Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update.
Rani Therapeutics Holdings Inc - Qtrly Loss per Share $0.29.
Rani Therapeutics Holdings Inc - Qtrly Loss per Share $0.29.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.71
Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.91
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.71
Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.91
More details on our Analysts Page.